Table 2.
Clinical information about breast cancer features from tissues used to establish primary cell cultures. na. not analyzed
| Cancer cell culture | Patient's age | Histologic type | Clinical stage | Tumor markers | ||||
|---|---|---|---|---|---|---|---|---|
| Estrogen receptor (%) | Progesterone receptor (%) | HER2 | Ki.67 (%) | Cytokeratin 5 | ||||
| CF1 | 31 | IDC | Stage IIA (T2, N0, M0) | 25 | 15 | + | 5 | Negative |
| TB2 | 41 | IDC | Stage IIA (T1c, N1, M0) | 100 | 90 | − | 20 | na |
| MC5 | 61 | IDC | Stage IA (pT1c, pN0 (sn)(i‐)) | 80 | 40 | + | 10 | Negative |
| MS6 | 74 | IDC | Stage IA (pT1c, pN0 (sn)(i‐)) | 100 | 60 | − | 10 | Negative |
| MC8 | 62 | IDC | Stage IIB (pT2, pN1a (1/16)) | 100 | 50 | − | 10 | Negative |
| KB10 | 62 | IDC | Stage IA (pT1c, pN0 (sn)(i‐)) | 100 | 20 | − | 5 | Negative |
| MG11 | 47 | IDC | Stage IA (pT1c, pN0 (sn)(i‐)) | 90 | 80 | − | 20 | Negative |
| MP13 | 73 | IDC | Stage IA (pT1b, pN0 (sn)(i‐)) | 90 | 0 | − | 10 | Negative |